Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TScan Therapeutics (TCRX)
NASDAQ:TCRX
Holding TCRX?
Track your performance easily
TScan Therapeutics (TCRX) Ownership Overview
16.28% Insiders
7.94% Mutual Funds
5.31% Other Institutional Investors
10.12% ETFs
60.35% Public Companies and Individual Investors
The ownership structure of TScan Therapeutics (TCRX) stock is a mix of institutional, retail, and individual investors. Approximately 23.37% of the company’s stock is owned by Institutional Investors, 16.28% is owned by Insiders, and 60.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 24, 2024 | Barbara Klencke Director | xxxxxxxxxxxxx | $26450 |
| Aug 27, 2024 | Barbara Klencke Director | xxxxxxxxxxxxx | $56100 |
| Aug 27, 2024 | Zoran Zdraveski Chief Legal And Strategy Officer | xxxxxxxxxxxxx | $951885 |
| Dec 21, 2023 | Timothy Barberich Director | xxxxxxxxxxxxx | $142263 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $956428 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,224,600 | Insider | 10.73% | 29,780,220 | |
| 2,784,792 | Institution | 5.72% | 15,873,314 | |
| 2,528,583 | Insider | 5.19% | 14,412,923 | |
| 2,227,492 | Institution | 4.57% | 12,696,704 | |
| 1,836,546 | Institution | 3.77% | 10,468,312 | |
| 1,492,922 | Institution | 3.07% | 8,509,655 | |
| 1,046,916 | Institution | 2.15% | 5,967,421 | |
| 681,015 | Institution | 1.40% | 3,881,786 | |
| 418,639 | Institution | 0.86% | 2,386,242 | |
| 411,841 | Institution | 0.85% | 2,347,494 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,836,546 | Institution | 3.77% | 10,468,312 | |
| 681,015 | Institution | 1.40% | 3,881,786 | |
| 418,639 | Institution | 0.86% | 2,386,242 | |
| 411,841 | Institution | 0.85% | 2,347,494 | |
| 190,290 | Institution | 0.39% | 1,084,653 | |
| 112,941 | Institution | 0.23% | 643,764 | |
| 52,005 | Institution | 0.11% | 296,429 | |
| 38,300 | Institution | 0.08% | 218,310 | |
| 29,605 | Institution | 0.06% | 168,749 | |
| 27,590 | Institution | 0.06% | 157,263 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,370,394 | Institution | 2.81% | 6,824,562 | |
| 1,046,916 | Institution | 2.15% | 5,967,421 | |
| 1,028,547 | Institution | 2.11% | 5,862,718 | |
| 645,284 | Institution | 1.33% | 3,213,514 | |
| 223,606 | Institution | 0.46% | 1,274,554 | |
| 175,945 | Institution | 0.36% | 876,206 | |
| 128,992 | Institution | 0.26% | 735,254 | |
| 88,758 | Institution | 0.18% | 505,921 | |
| 27,956 | Institution | 0.06% | 161,586 | |
| 21,210 | Institution | 0.04% | 122,594 |
FAQ
Who Owns TScan Therapeutics (TCRX)?
According to the latest TipRanks data, approximately 5.31% of the company's stock is held by institutional investors, 16.28% is held by insiders, and 60.35% is held by retail investors.
What percentage of TScan Therapeutics (TCRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.31% of TScan Therapeutics (TCRX) stock is held by institutional investors.
What percentage of TScan Therapeutics (TCRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.35% of TScan Therapeutics (TCRX) stock is held by retail investors.
Who owns the most shares of TScan Therapeutics (TCRX)?
Lynx1 Capital Management LP owns the most shares of TScan Therapeutics (TCRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.